Adial Pharmaceuticals (ADIL) vs BioLineRx (BLRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioLineRx (BLRX) has outperformed Adial Pharmaceuticals (ADIL) over the past year, losing 50.3% versus a loss of 59.1%. Over five years, BLRX leads with a -98.2% price change compared with -99.8% for ADIL. BioLineRx is the larger company by market cap ($11.0 million vs $10.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADIL | BLRX |
|---|---|---|
| Share price | $3.99 | $2.20 |
| Market cap | $10.46M | $10.95M |
| 1-day change | -0.13% | -0.23% |
| YTD return | -27.45% | -20.40% |
| 1-year return | -59.08% | -50.34% |
| 5-year return | -99.84% | -98.20% |
| EPS (TTM) | $-20.65 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.75 | $4.50 |
| 52-week low | $1.31 | $2.15 |
| Distance from 52-week high | -62.93% | -51.11% |
| Average volume | 56.77K | 16.27K |
| Shares outstanding | 2.63M | 4.98M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ADIL vs BLRX FAQ
Which is bigger, Adial Pharmaceuticals or BioLineRx?
BioLineRx (BLRX) is larger, with a market capitalization of $10.95M compared with $10.46M for Adial Pharmaceuticals (ADIL).
Which stock has performed better over the past year, ADIL or BLRX?
BLRX returned -50.34% over the past 12 months, compared with -59.08% for ADIL (price return, excluding dividends). Past performance does not predict future results.
Are Adial Pharmaceuticals and BioLineRx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.